Clinical Trial Update: Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 trial evaluating nabilone as an adjunct to gabapentin for neuropathic pain in multiple sclerosis, assessing ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Neuropathic Pain

Drugs mentioned

• Gabapentin (Gabapentin)
• Nabilone (nabilone)

Snippet

Sponsor: University of Manitoba | Conditions: Neuropathic Pain, Multiple Sclerosis | Phase 4 | Status: COMPLETED